Morepen Laboratories announced a substantial drop in standalone net profit for the quarter ended March 2016. During the quarter, the profit of the company declined 82.45% to Rs 27.69 million from Rs 157.78 million in the same quarter previous year.
Revenues for the quarter jumped 44.79% to Rs 1,235.93 million, compared with Rs 854 million for the prior year period.
Operating margin for the quarter stood at 145.21 percent as compared to 752.16 percent for the previous year period. Operating Income for the quarter was Rs 1,794.64 million, compared with Rs 6420.33 million in the previous year period.
Earnings per share for the quarter stood at Rs 0.06, registering 82.86% decline over previous year period.
Quarterly Results - Standalone (Rs in mn) |
As at | Mar - 16 | Mar - 15 | %Change |
Revenues | 1,235.93 | 853.58 | 44.79 |
Net Profit | 27.69 | 157.78 | (82.45) |
Diluted EPS | 0.06 | 0.35 | (82.86) |
Shares of the company declined Rs 1.8, or 6.05%, to trade at Rs 27.95. The total volume of shares traded was 2,089,286 at the BSE (3.25 p.m., Tuesday).